What if cancer cells are using a signaling shortcut we’ve been missing? Scientists uncovered a mechanism in a key cell-to-cell communication system—insight that could point to more effective therapies.
At the American Association for Cancer Research meeting, new pancreatic cancer research highlighted targeted drugs and personalized vaccines that could revolutionize how physicians treat this deadly disease.
Scientist and musician Dawei Kumaki, MD, PhD, blends laboratory research with orchestral composition, showing how curiosity, creativity, and discovery can connect science and music in unexpected and inspiring ways.
Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children with T-ALL, potentially enabling clinicians to make faster, personalized treatment decisions.
On this episode, Huntsman Cancer Institute researchers and patients share how scientific discoveries, clinical trials, and targeted therapies extend lives—and offer hope.
A Huntsman Cancer Institute researcher evaluated a noninvasive skin imaging technology that accurately discriminates between common moles and melanoma, potentially enhancing melanoma screening while reducing the need for unnecessary biopsies.
Advancing detection of prostate cancer, a new imaging drug targets PSMA—a protein marking cancer cells—helping physicians identify disease earlier and guiding patients toward timely, confident treatment decisions.
The STELLAR research trial found that a new combination therapy improved survival rates for patients with grade 3 astrocytoma, an aggressive form of brain cancer.
Huntsman Cancer Institute opens the Mountain West’s first combined angio-CT suite, enhancing cancer care with same-day imaging, improved outcomes, and reduced travel for patients needing complex interventional treatments.
Recent national rankings highlighted strong clinical outcomes, specialized treatment, research leadership, and patient-centered care, securing Huntsman Cancer Institute’s position among the top cancer centers in the United States.
Researchers at Huntsman Cancer Institute found that lipids fuel growth in triple-negative breast cancer cells. High-fat diets like keto could unintentionally worsen outcomes for breast cancer patients with obesity.
Huntsman Cancer Institute leads in robotic cancer surgery with single-port, Ion robotic bronchoscopy and da Vinci 5 systems, enhancing precision, access, and recovery while training surgeons nationwide in advanced techniques.
Utah’s $33 million investment fuels AI, advanced computing, and secure data innovation—strengthening health research and discovery statewide through leadership at the University of Utah and Huntsman Cancer Institute.
